Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
This study has been completed.
Sponsor:
NCIC Clinical Trials Group
Information provided by:
NCIC Clinical Trials Group
ClinicalTrials.gov Identifier:
NCT00377052
First received: September 13, 2006
Last updated: June 21, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2011 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |